Podcasts about yahoo

Scott Connor (@CharlesChillFFB) is back after week 15 of the 2025 season with Destination Dynasty! In Episode 123, Scott talks about how third-round picks are used in lineup dynasty leagues using the 2025 season trade results. What is the most popular trade commodity for a third? How much credit do they receive in leverage trades? Some extra TE flex data to discuss heading into the upcoming roster construction series! Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Amy and T.J. talk to the expert on gift giving following their most recent column for Yahoo.com. Associate professor Dr. Julian Givi studies gift giving for a living and tells us the do’s and dont’s for picking the perfect present. He also gives us an unexpected pro-tip that research shows could make the difference between someone liking your gift and LOVING it!See omnystudio.com/listener for privacy information.

Amy and T.J. talk to the expert on gift giving following their most recent column for Yahoo.com. Associate professor Dr. Julian Givi studies gift giving for a living and tells us the do’s and dont’s for picking the perfect present. He also gives us an unexpected pro-tip that research shows could make the difference between someone liking your gift and LOVING it!See omnystudio.com/listener for privacy information.

Amy and T.J. talk to the expert on gift giving following their most recent column for Yahoo.com. Associate professor Dr. Julian Givi studies gift giving for a living and tells us the do’s and dont’s for picking the perfect present. He also gives us an unexpected pro-tip that research shows could make the difference between someone liking your gift and LOVING it!See omnystudio.com/listener for privacy information.

Jeff Mueller (@jmthrivept), Doctor of Physical Therapy, hosts the DD Injury Podcast, covering all of the injuries we are monitoring as we enter week 15 of the 2025 NFL season. This week we cover key players including Jets QBs, Geno Smith, Philip Rivers, Alvin Kamara, Nick Chubb, Woody Marks, Breece Hall, Christian McCaffrey, De'Von Achane, Josh Jacobs, Marvin Harrison Jr, Parker Washington, Tee Higgins, Rome Odunze, Pat Bryant, Quentin Johnston, Davante Adams, Dalton Kincaid, David Njoku, Mark Andrews and more! Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Scott, Shane, and Ty are here to talk about the start of the playoffs. There are no more "we'll get them next week" outcomes. Win or go home!

Amy and T.J. talk to the expert on gift giving following their most recent column for Yahoo.com. Associate professor Dr. Julian Givi studies gift giving for a living and tells us the do’s and dont’s for picking the perfect present. He also gives us an unexpected pro-tip that research shows could make the difference between someone liking your gift and LOVING it!See omnystudio.com/listener for privacy information.

Yahoo C.E.O. Jim Lanzone joins Dylan and Julia for a tour of the company's Apollo era, four years after the private equity behemoth bought the business for just $5 billion—nearly $120 billion shy of its peak valuation. Lanzone breaks down Yahoo's growth strategy: the metrics that actually matter, how the company monetizes at scale, and what the endgame looks like. They also dig into Yahoo's A.I. ambitions, and what it takes to run a mass-market consumer business in a media landscape focused on niche and specialized content. Learn more about Starbucks industry-leading benefits at ⁠starbucks.com/partners⁠⁠.⁠ For more great episodes like this, subscribe to The Grill Room here To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Ray & JRich are here to preview all things Week 15, from the top games, injuries, and biggest news that impact this week's matchups. They will touch on the Buccaneers epic 14-point 4th quarter collapse to lose to the Falcons at home, and what it means for their playoff chances. They will dive into the players that project to perform well this week and who they might avoid, along with some start/sit advice for the fantasty football playoffs. So please bring your questions and a coffee, and let's have a day! Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's recap, we covered that the Google December 2025 core update was unleashed. Google also said more core updates are definitely on their way and one should be coming soon Google also updated its...

Learn how businesses tap into billions of monthly organic users through MSN.com, Bing, and Yahoo—without ads. Real strategies reveal traffic growth, sales impact, and the ROI of strategic content amplification. Ethos Media & Marketing LLC City: Washington Address: DC - MD - VA - LA - FL Website: https://www.ethosm2.com

Jim Lanzone (CEO of Yahoo, former CEO of Tinder & CBS Interactive) joins Dan Nathan to pull back the curtain on one of the most fascinating turnaround stories in tech history. With 90% reach across the US internet and profitability that would make most public companies jealous, Jim explains why Yahoo is quietly dominating while the world isn't looking. They discuss the "original sin" deal in 2000 where Yahoo accidentally helped build the Google monopoly, the similarities between the Dot Com crash and today's AI boom, and the exact playbook Apollo is using to revitalize the brand for a potential IPO. —FOLLOW USYouTube: @RiskReversalMediaInstagram: @riskreversalmediaTwitter: @RiskReversalLinkedIn: RiskReversal Media

Welcome to Best Ball Report Card!

Scott and Shane discuss the start of the fantasy playoffs and what do start doing over the next few weeks if you are OUT of the race. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

ESPN's Field Yates just dropped a brand new 2026 NFL Mock Draft, so you know we had to break it down. In this video I go pick-by-pick through his full first round. I'm talking fits, scheme, fantasy and dynasty angles, where I agree with Field and where I'm completely out, plus what this mock tells us about the 2026 NFL Draft class as we head deeper into draft season. Check out Field Yates' full 2026 NFL Mock Draft on ESPN here: https://www.espn.com/nfl/draft2026/story/_/id/47243299/2026-nfl-mock-draft-first-round-predictions-32-picks-field-yates ⏱️ TIMESTAMPS 00:00 – Intro 01:30 – New York Jets – Fernando Mendoza 02:56 – Las Vegas Raiders – Dante Moore 04:45 – Tennessee Titans – Arvell Reese 05:26 – Cleveland Browns – Carnell Tate 07:03 – New Orleans Saints – Francis Mauigoa 07:53 – Washington Commanders – David Bailey 08:27 – New York Giants – Jordyn Tyson 09:37 – Arizona Cardinals – Spencer Fano 09:56 – Los Angeles Rams – Caleb Downs 11:01 – Cincinnati Bengals – Rueben Bain Jr. 11:53 – Minnesota Vikings – Mansoor Delane 12:40 – Miami Dolphins – Keldric Faulk 13:18 – Baltimore Ravens – Peter Woods 14:12 – Kansas City Chiefs – Jeremiyah Love 15:49 – Dallas Cowboys – Sonny Styles 16:45 – Carolina Panthers – CJ Allen 17:26 – Detroit Lions – Caleb Lomu 18:05 – New York Giants – Avieon Terrell 18:49 – Tampa Bay Buccaneers – Kenyon Sadiq 19:28 – Pittsburgh Steelers – Makai Lemon 20:10 – Philadelphia Eagles – Jermod McCoy 21:22 – Houston Texans – A'Mauri Washington 22:05 – Chicago Bears – Cashius Howell 22:50 – Los Angeles Chargers – Olaivavega Ioane 23:45 – Buffalo Bills – Denzel Boston 24:30 – San Francisco 49ers – Caleb Banks 25:32 – Cleveland Browns – Kadyn Proctor 26:15 – Dallas Cowboys – Damon Wilson II 27:10 – Seattle Seahawks – Brandon Cisse 27:52 – New England Patriots – Colton Hood 28:33 – Los Angeles Rams – Ty Simpson 30:27 – Denver Broncos – Chris Bell 31:08 – Final thoughts & what's next on the channel Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Marcus Fontoura has led engineering teams at IBM, Yahoo, Google, and Microsoft...building the very systems that power our digital lives. Now, as the author of Human Agency in a Digital World, he's asking a more profound question: how do we stay in charge of the technology we create? Scott and Marcus explore what it means to move from being passengers to pilots in an age of automation — through ethics, education, and intentional design.https://fontoura.org

Yahoo! Sports NFL writer Frank Schwab Sports Roulette Final thoughts

Yahoo! Sports NFL writer Frank Schwab

Hour 1 USU Athletic Director Cameron Walker talks bowl prep.  What was Sherrone Moore thinking? Michigan has fired him after an alleged scandal.  Utah Jazz Insider Ben Anderson.  Hour 2 Real Salt Lake President John Kimball Good, Bad & Ugly Whole World News Hour 3 Yahoo! Sports NFL writer Frank Schwab Sports Roulette Final thoughts

In today's episode, we have the pleasure to interview Kary Oberbrunner, author of more than a dozen books including You Are An IP CompanyKary is a Wall Street Journal and USA Today bestselling author, award-winning novelist, screenwriter, and inventor. As CEO of Igniting Souls and Instant IP, he helps authors, entrepreneurs, and influencers publish, protect, and promote their intellectual property and turn it into 18 streams of income. Once a young man who battled stuttering, depression, and self-injury, today he's a transformational leader whose work has been featured in Entrepreneur, Forbes, CBS, Fox News, Yahoo, and more.In this episode, you'll learn why your ideas are more vulnerable than ever in the age of AI, how to turn your books, frameworks, and signature phrases into real IP assets, and the simple “smartphone to smart contract in 60 seconds” process Kary created so you never get locked out of your own ideas again.We hope you enjoy this incredible conversation with Kary Oberbrunner.To Learn More about Kary and buy his books visit: The Books: https://www.amazon.com/stores/author/B001JSJJY0/allbooks?ingress=0&visitId=ba37f22b-9108-4b93-9c12-78004ed96bdb&ccs_id=23351f2a-a3c4-45eb-9c5d-2e4495e0430dWebsite/Socials: https://ignitingsouls.com/apply/https://www.linkedin.com/in/karyoberbrunnerhttps://www.youtube.com/user/KaryOberbrunnerhttps://www.facebook.com/karyoberbrunnerauthor/https://www.instagram.com/kary.oberbrunner/____________________________________________Join the world's largest non-fiction Book community!https://www.instagram.com/bookthinkers/The purpose of this podcast is to connect you, the listener, with new books, new mentors, and new resources that will help you achieve more and live better. Each and every episode will feature one of the world's top authors so that you know each and every time you tune-in, there is something valuable to learn. If you have any recommendations for guests, please DM them to us on Instagram. (www.instagram.com/bookthinkers)If you enjoyed this show, please consider leaving a review. It takes less than 60-seconds of your time, and really makes a difference when I am trying to land new guests. For more BookThinkers content, check out our Instagram or our website. Thank you for your time!

This “Best of 2025” episode highlights insights from Shannon Shae Montoya, Global Head of B2B Marketing, Sponsorships, and Events at Yahoo; Toby Espinosa, Vice President of Ads at DoorDash; Adam Kornblum, Chief Creative Officer at L'Oréal; and Merill Hollander, founder of Fiametta, as they discuss how data-driven creativity, storytelling, and bold experimentation are shaping the future of marketing, retail media, beauty, and fine jewelry. Hosted on Acast. See acast.com/privacy for more information.

Join D-Mac ( @nbafantasybible ) and Matty G as they discuss several Buy Low Trade targets in Week 8 of the NBA Fantasy Basketball Season. Take advantage of knee-jerk reactions to some of your favorite fantasy players, or look to exploit league-mates struggling with injuries. D-Mac and Matty G also check out some wild Yahoo league trades for these players. Let us know what you think of these crazy buy lows currently being pulled off! LET"S GO AND WIN SOME LEAGUES! Join Our FREE Community: https://www.bleavinfantasy.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Yahoo Senior NFL reporter Charles Robinson joins the show for his usual visit breaking down all things NFL.  What is he hearing in regards to the offseason coaching moves?  What do we make of all the heat on Jalen Hurts this week?  We wrap up the show with your final phones.

This “Best of 2025” episode highlights insights from Shannon Shae Montoya, Global Head of B2B Marketing, Sponsorships, and Events at Yahoo; Toby Espinosa, Vice President of Ads at DoorDash; Adam Kornblum, Chief Creative Officer at L'Oréal; and Merill Hollander, founder of Fiametta, as they discuss how data-driven creativity, storytelling, and bold experimentation are shaping the future of marketing, retail media, beauty, and fine jewelry. Hosted on Acast. See acast.com/privacy for more information.

A young hiker vanishes in the woods, and the search leads police across multiple states to a mysterious drifter living deep in the forests. What they uncover is far darker than anyone imagined. Links: Patreon: https://www.patreon.com/murderwithmyhusband NEW MERCH LINK: https://mwmhshop.com Discount Codes: https://mailchi.mp/c6f48670aeac/oh-no-media-discount-codes Twitch: twitch.tv/throatypie Instagram: https://www.instagram.com/paytonmorelandshow/ Discount Codes: https://mailchi.mp/c6f48670aeac/oh-no-media-discount-codes Watch on Youtube: https://www.youtube.com/channel/UCUbh-B5Or9CT8Hutw1wfYqQ Listen on Apple: https://podcasts.apple.com/us/podcast/into-the-dark/id1662304327 Listen on spotify: https://open.spotify.com/show/36SDVKB2MEWpFGVs9kRgQ7 Case Sources: Making a Serial Killer - Season 2 Episode 2, “Gary Hilton” Wild Crime – Season 3, episodes 1, 2, 3, and 4 United States Attorney's Office - https://www.justice.gov/usao-wdnc/pr/gary-michael-hilton-sentenced-four-life-sentences  Court TV - https://www.youtube.com/watch?v=hc5mR0ndQCE People - https://people.com/national-forest-serial-killer-confesses-2007-dismemberment-murder-florida-nurse-11712002 WYFF 4 - https://www.wyff4.com/article/serial-killer-sentenced-for-nc-murders/7004143  Yahoo! News - https://www.yahoo.com/news/gary-michael-hilton-national-forest-150259738.html NBC News - https://www.nbcnews.com/id/wbna23769881  ABC News - https://abcnews.go.com/US/hulu-documentary-missing-womans-case-sparked-investigation-serial/story?id=105180020 WLOS News 13 - https://www.youtube.com/watch?v=HB4iQONtZ4I  CBS News - https://www.cbsnews.com/news/gary-michael-hilton-suspected-serial-killer-gets-death-penalty-in-fla-for-2007-beheading-murder/  Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this week's LIVE episode of Dynasty Theory, Dan, Mitch, and John spend some time reviewing the 2025 rookie class production/outlook, veteran performances of note, and a couple offseason predictions. For more conversations on these topics, join the DDFFB Patreon. Tune in for actionable dynasty advice to stay ahead in your leagues! Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Ray & JRich discuss the breaking report that Philip Rivers, who retired after the 2020 season, is coming back to Indianapolis, where he last played, to try to save the Colts' season after Daniel Jones' Achilles injury. They will also discuss the fallout from the Eagles-Chargers game, in which the Eagles continued to show their inconsistent offense. They will also dive into some of the non-playoff teams, what we should look forward to for those who are out of it, and how things are shaking up across the league as we head into the closing few weeks of the season. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community ⁠https://ddfantasyfootball.com/subscriptions/⁠ Subscribe to the Youtube Channel DDFFB ⁠https://www.youtube.com/@DDFFB⁠ Subscribe to Ray's Channel: ⁠https://www.youtube.com/@RayGQue⁠ Check out All of Ray's Articles at Yahoo!: ⁠https://sports.yahoo.com/author/ray-garvin/⁠ Follow Ray on Bleacher Report: ⁠https://br.app.link/7ExIDsWfHVb⁠

Thank you to everyone who tuned in live today! In this livestream conversation, I sat down with Substack writer and podcaster Jonathan Small to talk about what it really means to navigate work, identity, reinvention, and retirement as members of Generation X. Jon and I traveled different career paths. He moved from magazine publishing to digital media, podcasting, and entrepreneurship. Check out his current Substack publication, Small Talk. I shifted from a big-tech career (e.g., Apple, IBM, eBay, Yahoo) into independent coaching as a solopreneur. But we've both lived through the same constant pattern: industries rise, industries fall, and Gen X is constantly forced to reinvent itself.We talked about how traditional career expectations failed our generation. The idea of a stable, decades-long job with a pension evaporated. Entire fields collapsed (e.g., print magazines, early tech companies), and many people clung to the past too long, only to find themselves shut out of the future. What has kept the survivors afloat is adaptability. As I shared in the conversation, I've learned to watch the “canaries in the coal mine” and pivot before a company or industry fails. Jon had to make similar leaps as the print media industry imploded around him.A big theme was identity. Many Gen X professionals still define themselves by job titles, employers, or industries that may no longer exist. Jon and I both experienced that moment of losing our “main character” identity and having to figure out who we were without our familiar career spotlight. It's painful at first, but eventually liberating. Your profession is not your identity! The sooner you separate the two, the stronger and more resilient you become.We also talked about the realities of ageism, unstable 401(k)s, and the pressure of being the “sandwich generation,” caring for both aging parents and kids heading to college. It's no wonder so many Gen Xers feel anxious about retirement. But despite all of this, our generation remains remarkably resilient. Someone in the chat joked that we're the “Chumbawamba generation”—we get knocked down, we get back up again. And it's true.One of the most important takeaways from our conversation is the shift toward multiple income streams. Many of us no longer expect one job to provide all of our income, meaning, or stability. Check out Free Agent Nation by Daniel Pink. Jon and I both shared how life improved once we stopped forcing a single revenue source to carry everything. * More flexibility. * More time with family. * More control of our energy. * More meaningful work, on our own terms.We also touched on the growing loneliness many mid-career adults face, especially when office culture disappears. Building community (e.g., through platforms like Substack and online groups) and collaborating have become essential. Sharing your work publicly, even imperfectly, helps replace that lost connection. And as I emphasized, the antidote to fear isn't perfection. It's showing up consistently.We ended on a hopeful note. As Gen Xers, we're entering what Jon called Chapter Three of our lives. It's the stage where experience, autonomy, creativity, and wisdom finally converge (think Yoda). We don't need to chase the identity we had at 25. We get to design something new. The internet gives everyone the opportunity to build their own platform, reach people globally, and create a working life that fits who they are now.Would you like to talk with me about planning the next phase of your career? You can always schedule a complimentary call.

Brandon & Scott share their Dynasty Takeaways — covering this week's injuries, biggest risers, fallers, trade targets, and player trends across the league. Whether you're contending or rebuilding, this episode gives you actionable dynasty strategy you can use today. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Scott Connor (@CharlesChillFFB) is back after week 14 of the 2025 season with Destination Dynasty! In Episode 122, Scott goes through the current WR data in 2025 and how it matches up historically. What is trending? How do we adjust? Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Gangland Wire, Gary Jenkins interviews bestselling author Mark Shaw about his explosive new research into the JFK and RFK assassinations — and the hidden role of New Orleans Mafia boss Carlos Marcello. Shaw breaks down newly uncovered FBI documents, including Marcello's alleged 1985 prison confession claiming involvement in JFK's murder. We explore Marcello's long-running war with Robert Kennedy, the suspicious death of journalist Dorothy Kilgallen, and significant inconsistencies in the official story of RFK's assassination. This conversation challenges the lone-gunman narrative and exposes how organized crime, politics, and government investigations may have collided to shape American history. Subscribe to get notified about new content. 0:10 The Kennedy Connection 21:37 Sirhan’s Background Uncovered 31:56 The Role of Marcello in Assassinations 44:54 The Quest for Justice

Gerri Detweiler is a leading, nationally recognized financing and credit expert, with more than 20 years of experience.  Gerri shares her knowledge through contributed content in leading industry and national publications, and her articles have been featured on Yahoo!, MSN Money, ABCNews.com, CBSNews.com, NBCNews.com, Forbes, The Today Show website and many others  She is the author of seven books including her forthcoming book, The Ultimate Credit Repair Action Plan: A step-by-step guide to great credit to be released in late 2025. Gerri hosted her own talk radio programs for more than five years and she has been interviewed for more than 5,000 news stories. She is an international speaker and has testified before Congress on consumer credit legislation. Today, Gerri develops educational programs and content for small business owners for Nav, a financial health and credit platform that provides small businesses owners a dedicated space for accessing, building, managing their business and personal credit, tracking cash flow patterns, and understanding their financing options before they apply. During the show we discuss: Why business credit feels confusing—and how to simplify it What business credit is and why it's critical for small business success How monitoring business credit across all three bureaus supports smarter decisions How quickly business credit scores can improve with tradeline reporting Why tracking business and personal credit together matters What tradelines are and how they strengthen business credit profiles The funding options unlocked by strong business credit How Nav matches businesses with the right financing opportunities Why cash flow tracking is essential to financial health How strong business credit increases loan approval odds The common mistakes that limit business credit growth How to find and fix errors on business credit reports What sets Nav's credit monitoring and reporting apart How business credit separates—and protects—personal finances Resources: https://www.nav.com/gerri/    

NFL Week 14 was pure chaos. Ray & JRich break down the Texans' statement win over Patrick Mahomes and the Chiefs, Shedeur Sanders vs Cam Ward and the wild Titans-Browns finish, the Bills-Bengals snow show, Rams offensive explosion, Packers edging Caleb Williams, and Steelers-Ravens with massive AFC North implications. We'll also hit Saints-Bucs, Dolphins-Jets, Seahawks-Falcons, Jags-Colts, Vikings-Commanders and what it all means for fantasy football, dynasty value and the playoff race — plus the College Football Playoff matchups being set. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community ⁠https://ddfantasyfootball.com/subscriptions/⁠ Subscribe to the Youtube Channel DDFFB ⁠https://www.youtube.com/@DDFFB⁠ Subscribe to Ray's Channel: ⁠https://www.youtube.com/@RayGQue⁠ Check out All of Ray's Articles at Yahoo!: ⁠https://sports.yahoo.com/author/ray-garvin/⁠ Follow Ray on Bleacher Report: ⁠https://br.app.link/7ExIDsWfHVb⁠

Visibility on Purpose, founded by Lydia Bagarozza and Bridget Sicsko, is redefining how founders and small business owners approach PR. In this episode, they break down how their PR strategy studio helps brands get seen, featured, and remembered—without relying on expensive agencies or guesswork.Lydia has led campaigns for top consumer brands sold at Ulta, Target, Amazon, and Whole Foods, while Bridget brings the storytelling expertise of a former book publisher and speaker, helping founders craft narratives that consistently land in USA Today, Time Magazine, Yahoo, Fortune, mindbodygreen, and leading podcasts.We dive into:• The gap between DIY PR and traditional agencies• What founders truly need to secure meaningful media• How to build story angles that attract journalists• What Visibility on Purpose teaches that most PR pros don't• Real examples of brand features and how they happenedThe PR Podcast is a show about how the news gets made. We talk with great PR people, reporters, and communicators about how the news gets made and strategies for publicity that drive business goals. Host ⁠⁠Jody Fisher⁠⁠ is the founder of Jody Fisher PR and works with clients across the healthcare, higher education, financial services, real estate, entertainment, and non-profit verticals. Join the conversation on ⁠⁠Facebook⁠⁠, ⁠⁠Twitter⁠⁠, ⁠⁠Instagram⁠⁠, and ⁠⁠TikTok⁠⁠ at @ThePRPodcast.

Dr. Pedro Barata and Dr. Ravin Garg discuss strategies to increase trial representation, including leveraging trial navigators and prioritizing pragmatic trial models, as featured in the ASCO Educational Book article, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care." TRANSCRIPT Dr. Pedro Barata: Hello, and welcome to By the Book, a podcast from ASCO featuring compelling perspectives from authors and editors of the ASCO Educational Book. I'm Dr. Pedro Barata. I am a medical oncologist at University Hospital Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I am also the associate editor of the ASCO Educational Book. We know that in recent years, the oncology community has increasingly prioritized the need to modernize clinical trial eligibility, reduce patient burden, and enhance diversity in trial participation. On that note, today we will be speaking about ways to enhance access to clinical trials with Dr. Ravin Garg. He is a hematologist oncologist at Maryland Oncology Hematology and also an assistant professor of oncology at Johns Hopkins Hospital in Baltimore. Dr. Garg is also the co-author of a fantastic paper in the ASCO Educational Book titled, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care."  Dr. Garg, welcome. Thanks for being here, and congrats on your paper. Dr. Ravin Garg: Thank you for having me, Pedro. I am excited to be here. Dr. Pedro Barata: [KI1]  Your paper is a wonderful, multidisciplinary piece that actually features perspectives from the different stakeholders, right? The patient advocacy, industry, community practice, and academia about these challenges in making trials more available. This podcast is a wonderful platform. It reaches out to a lot of folks within our community. So, I will start by asking you the obvious. Why do you think it is a must read for our community, for our listeners? Dr. Ravin Garg: So Pedro, thanks again for inviting me. You do a great job with these podcasts.  So, I think first and foremost, oncologists right now are under a lot of stress, just in terms of clinical volume. There is concern for research money, and how we get the best care for our patients. So I think this article is very important because it helps bring together, as you had mentioned, the stakeholders throughout academic to community practice and everywhere in between, and try to find how, as a team with different oncologists who partake in different aspects of oncology, can come together to streamline the process to try to get our patients on trials, or certainly have them have availability of trials, just if they are interested in going on them. Being in practice, we have had several challenges that we can talk about throughout this podcast, but I think it is a very important paper because it recognizes that at the end of the day, it takes a team effort for all of us in academics, community, industry, and pharmaceuticals to really come together as a team to really help put forth the trials for our patients. Dr. Pedro Barata: So, from the perspective of a community oncologist, how do you put together, or maybe you can describe some of the challenges that you see to increase trial participation in the community? Dr. Ravin Garg: Yes, Pedro, that is a great question, and it is something that I keep on thinking about and trying to find ways to be better at it myself. But I will say some of the challenges as a community doctor that I have seen for myself and talking to other colleagues. Number one, I do think there is a lot of stress on doctors in the community in general, Pedro. Oftentimes we are tasked to see a wide smorgasbord of patients, so we may not have the luxury of being a specialist in any particular tumor subtype. Like oftentimes, we will have to see lung cancer, the next one will be breast cancer, the next one could be CML, the next one could be thrombocytopenia. And as you know better than I do, Pedro, the field in each one of these disciplines is changing so rapidly: molecular genomics, radioligand treatments, different imaging tests, MRD testing for some of our hematologic malignancies. And I think one challenge we have in community is just keeping up with the basics of Oncology 101. In the process of doing that, it can be very difficult to sometimes remember that we have very exciting trials available for our patients. So, I think a lot of it is the day in and day out of being an oncologist is so taxing at times that oftentimes a research trial is not the first thing in our head space when we see a patient. I think number two, Pedro, at least in the community, and perhaps this is with academics too, is that we are bombarded, I would say, by a lot of messaging these days. We have in-baskets to go through, labs to go through, things of that nature. And in the process of a patient visit, seeing them, doing an exam, taking a history, trying to go over the NCCN guidelines on best practice for how to manage their care, at least for me at times, it is very hard to remember, "Hey, there might be a great trial available, whether within our network or maybe partnering with an academic center." So getting through a day can be fraught with a lot of peril and just difficulties, I would say. And I would say number three, Pedro, at least as, you know, I am in a private practice where I do see a wide range of benign and malignant hematology and solid tumors, so I would not call myself a specialist. And I think the challenge with that, at least for trials, Pedro, is that when you are a specialist or perhaps you are focusing on a couple of disease subtypes, you become more of an authoritative voice in those types of tumors, and you might be more aware of the trials within your network or perhaps in proxy with an academic center that you can offer your patient. So I think when sometimes we spread ourselves too thin, it can be very hard to be a thought leader, if you will, in a particular subtype of a malignancy, let's say, and maybe not be aware of a trial that could be really well-suited for your patient. In terms of ideas that myself and colleagues have had in terms of helping mitigate against some of these, I would say, setbacks or issues in the practice for trial enrollment, some of the things we have talked about, Pedro, is, number one, is we do partner with academic centers. So we live here in Maryland. We have several really fantastic academic centers. So, you know, oftentimes, not just within our practice of Maryland Oncology Hematology, we have a lot of great trials available here too, for certain, but in addition to that, we will often times work with doctors at Georgetown, Johns Hopkins, and Maryland if they have a compelling trial that we do not have within our network. It is really of the patient's interest, Pedro, to reach out to them in a collaborative manner to see if they have a trial that might be really compelling for your patient. So I do find myself collaborating a lot with colleagues in, like talented like yourself in academics. You know, I think you do a lot of GU malignancies. So as an example, like partnering with colleagues who are GU experts and say, "Hey, we have a patient with stage IV renal cell. These are the standard options I know, but are there any trials that you might have available?" I think the other thing that has been very helpful for us is having navigators within research, Pedro. Like as an example, what has really helped the uptake of trial enrollment for our center in Annapolis is having a research navigator because often times what they can do is, a priori, Pedro, before you see the patient and you are kind of formulating a standard of care treatment plan perhaps, they might tug you on the shirt and say, "Hey, we have a great trial here through Sarah Cannon, or there might be something else out there." And being aware of that when you go into a patient's room really provides a nice arena, if you will, to go and say, "The standard of care is here, but hey, we have a trial option that might be well suited for you, maybe perhaps even better, that we can talk about, too." So having research support in the community is really a huge boon, I think, Pedro, for us to really increase our enrollment for patients onto trials. Dr. Pedro Barata: Yes, I really love that, Ravin. So, let me switch gears a bit. I would love for you to talk a little bit about patient advocacy because they do play a huge role in cancer, and they address many barriers. How do you think we should leverage the patient advocacy groups to reduce patient burden and maybe have them really leverage patient advocacies to improve representation in clinical trials? What do we think we can do more? Dr. Ravin Garg: Oh, Pedro, I think they are very critically important. As a clinical oncologist now, and I would say this is for anyone in the field of medicine, you are exactly right. I think patients are bombarded by information. There are a lot of things online, whether it be TikTok, Facebook, Google, Yahoo, and people really just have a lot of information given to them. And some of it is fact driven, and some of it is not, Pedro. And oftentimes, I do think there can be at times a mistrust with some medical personnel. I think we are in an era where we are seeing that to some degree with some attributes of medicine. And I think of it as an opportunity for education for the patient and for myself as a physician. And I think patient advocates, to your point, which was well taken, serve as a bridge to both. And what I mean is that, you know, patient advocates are wonderful. They are, I think, outstanding communicators. They almost are a neutral party, Pedro, where many patients feel that they are an independent source of information that is free of bias, if you will. They are there to provide support, emotional support, scientific support for patients so they can make an informed decision. So, in terms of our practice right now, patient advocates is something that we are evolving in that capacity, I would say, Pedro. I think now more than ever, having more people as bridges of communication with care providers along with patients is of critical importance. And I would venture a guess, and I think this has been published, where patient advocates really can help tremendously in familiarizing patients with trials and what they are all about and maybe clear up some misconceptions of what trials, what the mission of trials are. Because I do think some patients, at least I have had a few over the years, where when they hear the term trial, they almost think they are being experimented upon, when, in point of fact, they could really help advance their care. That messaging along the way for some can may be mixed up a little bit. And so I think patient advocates is a really great way to offer more information for patients with a source they find very independent and trustworthy, if you will. And it can really help expedite, and I think make a more fruitful conversation for care providers, whether academic or community, and they might be more open-minded in terms of enrolling onto a trial. Dr. Pedro Barata: Wonderful. Yes, I agree. I agree with you completely.  So let's focus a little bit now on the folks designing the studies. We usually call them the sponsors. It might be an academic sponsorship, if you will, but we can also have pharma being the sponsor of a study. The angle from an academic design, it is not necessarily the same as what happens when we have pharma. And from that angle, how do you think a more inclusive research can be promoted? Dr. Ravin Garg: Oftentimes with trials, I think keeping them simple, as simple as we can. And what I mean by that is, often times for trials, Pedro, even for care providers who are enrolling, it can be daunting when there are a lot of different things involved, particularly, let's say, for investigator sponsored, which are incredibly brilliant science, incredible, but it can be a little bit daunting for patients and even the referring physician to talk about getting translational specimens, imaging, traveling to certain centers to get scans and biopsies and even different diagnostic testing like PSMA testing for, you know, prostate cancer. And it can, I think, be very intimidating for patients in terms of what might be required of him or her to enter onto a trial. Like, "This is not what I signed up for. This is laborious. This is a full time job for me. Do I have to pay for parking to go to a city? Do I have to pay for these imaging tests? And do I have to stay in a place for my family to enroll onto a trial?" So I think keeping trials as simple as possible, but yet cull the data we need as investigators where we can really advance the care, hopefully get approval for a drug, but also learn more about the medication and how it works for our patients. So I think simplifying language for trial is very important. I know when I have gone over studies for patients, Pedro, if it is a voluminous amount of information, they can right away get very intimidated. "Like, oh my goodness, this is like a term paper for college again," you know? I am joking, but you know, keeping language simplified is very important, I think, number one. And I feel that sometimes when they are asked to do a lot of different diagnostic testing, which is very important for translational work, I 100% understand, but I do think sometimes patients can get a little bit off put, if you will, and frustrated with the whole process of doing it. The second thing for our patients, Pedro, that they have mentioned to us when we put them on trials, not just within our own site but elsewhere, is that it takes a lot of time in terms of collecting information, perhaps a washout period from their last standard of treatment prior to enrollment onto a study. Many patients, Pedro, as you know better than I do, are in maybe crisis in terms of their health and their cancer might be growing, promulgating out of control, and they worry about not being able to expeditiously start onto a treatment, onto a trial. So that can lead to a lot of frustration. And one thing that you brought up, which was outstanding for me, is the enrollment criterion for some of our patients is felt to be somewhat strict. We have had some patients who may have had a remote history of a stage I malignancy that was by all accounts in remission, you know, let's say 4 or 5 years in the past, and the risk of recurrence at this point would be incredibly low, but they may not be able to enter onto a study because of some stringent criterion put forth. And that can be a little bit frustrating. In fact, I have had one or two patients who, as an example, with kidney issues, but the GFR was about 60, like right near a cutoff that oftentimes, as you know, we use where you can get into trial or not. And you know, if they are at 58, as an example, and otherwise they are a picture of health, a great candidate for a trial that will likely advance their care, and if the entry criterion is too stringent, that might be a lost opportunity for all parties involved, all stakeholders, if you will. I do appreciate the criterion for entry onto studies cannot be too liberalized. You have to have a certain baseline, but there is a little bit of a gray area and tension, of sorts, if you will, where the patient has a comorbid illness that is a disqualifying offense, but in practicality, perhaps it shouldn't be, especially if they are motivated and there is an opportunity to really advance their care. We have run into, not often, but sometimes in the past, I should say, where patients have been very off put because we try to get them onto a study and there may have been a particular feature or attribute in their underlying care that they couldn't get onto it. So I think having a little bit more thoughtfulness, perhaps, in terms of entry criterion and practicality, if you will, I think would really help enrollment onto studies. Dr. Pedro Barata: Really well said. Is there anything else that you would like to tell our listeners before we wrap up the podcast today? Dr. Ravin Garg: I would say just macroscopically speaking, it is really an honor to be an oncologist. I think I speak for both of us. Anyone listening who is thinking about the field, it is tremendous. Just the research, the bravery of our patients, and the thoughtfulness of our scientists like Pedro and translationalists and clinical trialists is really awe inspiring. So I have really loved this field. I will say from a trial perspective, we really need to enter as many patients as we can onto trials because the science is so brilliant now, the genomic underpinnings of the tumor, we are making great strides as a team of clinicians and scientists, translationalists. So the more that we can get people onto trials and get approved drugs, it is going to help them out in the end. So I think it is such an important time for all of us to come together as a community, find the best way to help our patients out. And clinical trials have to be at the forefront of how we can continue to advance care for our patients. Dr. Pedro Barata: Yeah, no Ravin, I really agree with you. We really need to increase access to clinical studies, and actually your paper is a great step in that direction by raising awareness, bringing up solutions, and again, collaboration, collaboration, collaboration is really a multidisciplinary effort to accomplish that.  Thank you so much for sharing your fantastic thoughts and insights with us. Dr. Ravin Garg: Thank you, Pedro. I am- you do a wonderful job with these podcasts. I am really honored to meet you and to be part of this. Dr. Pedro Barata: And thank you to our listeners for your time today. I encourage you to check out Dr. Garg's article in the 2025 ASCO Educational Book. We will post a link to the paper in our show notes. And please join us again next month on By the Book for more insights on key advances and innovations that are shaping modern oncology. Thank you for your attention. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:          Dr. Pedro Barata   @PBarataMD    Dr. Ravin Garg Follow ASCO on social media:          @ASCO on X      ASCO on Bluesky     ASCO on Facebook       ASCO on LinkedIn       Disclosures:       Dr. Pedro Barata:   Stock and Other Ownership Interests: Luminate Medical   Honoraria: UroToday   Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon   Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas   Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck    Dr. Ravin Garg: Patents, Royalties, Other Intellectual Property: Creator, editor, and writer of hemeoncquestions.com  

Re-Air Date: 12–2-25 Unless you were a member in May of 2024, this episode of SOLVED! will be brand new to you! If you were a member back then, THANK YOU and this one is worth a re-listen. We're slowing down production for a little bit to reorganize our production processes, so enjoy this episode from our archives (and B.Y: before YouTube) where Jay!, Amanda, Deon, and Erin discuss: Ch. 1 - How supply and demand economics is not about "distribution of goods with the greatest efficiency" and is instead about nothing more than predatory greed Ch. 2 - How what we value as humans goes far beyond the price of commodities Ch. 3 - More examples of "enshitification" as companies reach inside our homes to control things we already bought Ch. 4 - How companies are restricting functionality to extract even more from us FOLLOW US ON: YouTube (This full episode premieres on YouTube on Friday - please share!) Bluesky Instagram Facebook Mastadon   REFERENCES: WELCOME TO PRICING HELL - The Atlantic The Gap Between the Price You See and What You Pay Is Getting Worse - The Wall Street Journal Welcome to the Golden Age of User Hostility - The Atlantic My Printer Is Extorting Me - The Atlantic Bought a Model Y? Tesla may charge you to use the battery's full range - Yahoo! Finance Corporate America Knows We're Miserable. Is a Toilet Bomb the Answer? - The Wall Street Journal   EXTRAS: 00:12:53 "Not everything that counts can be counted" by Billy Bragg 00:42:41 Best of the Left Ep. #1629 - "Hitting Where it Hurts in Our Era of Negative Partisanship: Messaging left-wing politics amid cultish politics" (Air Date: May 2024) 00:48:44 Best of the Left Ep. #1628 - "New Era of Antitrust for a New Era of Capitalism, Mega-Corporations and Big Tech" (Air Date: May 2024)   Join our Discord Server Reach us via Signal: Bestoftheleft.01 Leave a message at 202-999-3991   Produced by: Jay! Tomlinson Thanks for listening!

Scott, Shane, and Ty crush your trades as we enter the final week of the fantasy football regular season!

Yahoo's Frank Schwab joins the show to break down the NFL Week 14 slate. Anthony Dabbundo stops by to react to today's FIFA World Cup draw. Plus, PJ & Femi react to LeBron's double digit scoring streak ending last night.

Jeff Mueller (@jmthrivept), Doctor of Physical Therapy, hosts the DD Injury Podcast, covering all of the injuries we are monitoring as we enter week 14 of the 2025 NFL season. This week we cover key players including Justin Herbert, Jayden Daniels, Lamar Jackson, Alvin Kamara, Bucky Irving, Aaron Jones, Woody Marks, Trey Benson, Omarion Hampton, Chris Olave, Drake London, Marvin Harrison Jr, Mike Evans, Parker Washington, Jayden Reed, Rome Odunze, Pat Bryant, Darren Waller, Dalton Kincaid, and more! Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back to the All Gas Trade Show (AGTS) with Gabe (@iGabe_FF) and Ty (@TyDeclare44)! This week we're diving deep into the wide receiver landscape as dynasty managers face tough decisions heading into the final stretch of the season. Topics include: Tier down WR moves that actually make sense How to navigate volatility without panic-selling Justin Jefferson's long-term dynasty outlook Real WR deals straight from the DDFFB Discord How to match trades to your roster's timeline Market pockets you can exploit before values settle Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Scott Connor & Ray G dive into a pivotal Week 13 Trinity breakdown and shift into full dynasty-strategy mode with playoff season approaching. They analyze wide receiver environments, usage trends, long-term upside, and how the Trinity Tool is changing roster-construction logic. From AD Mitchell and Jaden Higgins to Marvin Harrison Jr., JSN, and the collapsing Chargers ecosystem — this episode is packed with actionable dynasty insights. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

It's Week 14 of the 2025 NFL Season. Join Crash & Doug as they break down Week 14 of the 2025 NFL Season. We will also be giving out our top prop bets on Prize Picks and a FREE Weeks membership to our Discord! If you're looking for the podcast to kick off the NFL DFS Season at the top of the leaderboard and stay up there all year, this is the podcast for you!

Scott and Shane channel their inner Jim Mora Sr. as we discuss the final part of the journey to the 2025 fantasy playoffs. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

On this week's LIVE episode of Dynasty Theory, Dan, Mitch, and John look at trade offers that might put contenders in a tough spot! Trading proven vets for a struggling elite asset – how much is too much when a title is within reach? For more conversations on these topics, join the DDFFB Patreon. Tune in for actionable dynasty advice to stay ahead in your leagues! Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices

Check out the full, hilarious episode here: Mom Wants Quaaludes for Mother's Day My Mom (@karenleepoter)  answers all my questions related to her past and future hopes and dreams (most of which involve the Avett Brothers, TikTok, porn, and quaaludes). We also discuss the Spring Awakening that we're experiencing as people are getting vaxxed and starting to mingle! Yahoo!

From under-16 social media bans in Australia to the sneaky reason your email should never go out exactly on the hour, this weekly rundown packs in plenty of usable takeaways and a little chaos. Jay Schwedelson connects policy shifts, inbox strategy, influencer math, and the latest AI land grab so you can keep your marketing sharp without living in a news feed. He even throws in some wild traffic stats and a Stranger Things rant that might make you question how old you feel right now.ㅤBest Moments:(00:16) Jay riffs on Australia's under 16 social media bans, Snapchat's behavioral signals, and why age gating is about to spread to the EU and US.(01:57) A dead-simple holiday email trick where not sending on the hour helps you dodge inbox clutter and lift open rates by around 15%.(03:15) Holiday influencer rate reality check for micro creators and why follower count means nothing without real engagement.(04:15) Jay makes the case for Team Gemini, breaking down fresh usage numbers and how it is catching up fast to ChatGPT.(05:09) Wild traffic stats reveal Yahoo and even Bing pulling more visits than ChatGPT, leaving Jay stunned at what people still type into their browsers.(06:34) From Wicked vs Zootopia 2 box office surprises to the very grown up Stranger Things cast still riding bikes, Jay wonders when nostalgia finally goes too far.ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/

Brandon & Scott share their Dynasty Takeaways — covering this week's injuries, biggest risers, fallers, trade targets, and player trends across the league. Whether you're contending or rebuilding, this episode gives you actionable dynasty strategy you can use today. Thank you for checking out the Podcast, be sure to follow and comment if you have any questions, we are always happy to answer any. For Access to our Premium Tools (Trinity, WAR & More) & Discord Community https://ddfantasyfootball.com/subscriptions/ Subscribe to the Youtube Channel DDFFB https://www.youtube.com/@DDFFB Subscribe to Ray's Channel: https://www.youtube.com/@RayGQue Check out All of Ray's Articles at Yahoo!: https://sports.yahoo.com/author/ray-garvin/ Follow Ray on Bleacher Report: https://br.app.link/7ExIDsWfHVb Follow us on Twitter: https://x.com/destinationdevy Become a Member on Youtube for access to the Dynasty Deal Show Live, Destination Chill and other member benefits, like priority reply to comments and unique badges and emojis: https://www.youtube.com/channel/UCV84gHvtBMXxzN9ZPI9XHfg/join Learn more about your ad choices. Visit megaphone.fm/adchoices